Improving imaging techniques for lung cancer treatments
Official title: A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
Funded at University of Washington · NIH-10906117 · Data updated 2026-11-12
This study is looking to improve how we use special imaging techniques to see how well new lung cancer treatments are working for patients with non-small cell lung cancer, using advanced technology that can be easily accessed online.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 15, 2021 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $549,873 |
| NIH project number | 5U24CA264044-04 |
| Project ID | NIH-10906117 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with non-small cell lung cancer who are considering or currently undergoing immune checkpoint inhibitor therapy.
✕Less likely to help
Patients with lung cancer who are not eligible for immune checkpoint inhibitor therapies or those with other types of cancer may not benefit from this research.
What this research studies
This research focuses on enhancing quantitative PET imaging methods to evaluate the effectiveness of immune checkpoint inhibitor therapies in patients with non-small cell lung cancer (NSCLC). By utilizing genetically-engineered mouse models, the team aims to develop and implement advanced imaging techniques that can be accessed through a web-based platform. This approach will help in better understanding patient responses to treatments and improve the overall management of lung cancer therapies.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes for lung cancer patients by optimizing therapy effectiveness monitoring.
How similar studies have gone: Previous research has shown promising results in using advanced imaging techniques for cancer therapies, indicating that this approach has the potential for success.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Kinahan, Paul E. — University of Washington
- Study coordinator: Kinahan, Paul E.
Related research
Other NIH-funded projects on the same topics.
-
PET/CT scans and blood tests to guide immunotherapy, chemotherapy, and focused radiation for metastatic lung cancer
This project combines PET/CT imaging and blood immune tests to help identify which people with metastatic non‑small cell lung cancer will benefit from immunotherapy plus chemotherapy and targeted radiation.
-
Improving PET/CT imaging for lung cancer immunotherapy
This project builds better PET/CT imaging methods and a shared online resource to help immunotherapy for people with non-small cell lung cancer.
-
Investigating how imaging and blood tests can predict responses to lung cancer treatments
This study is looking at how well patients with advanced lung cancer respond to a mix of chemotherapy and immunotherapy by using special imaging and blood tests, with the goal of personalizing treatments to help improve survival and reduce side effects.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Adding PSMA PET/CT imaging to liver cancer care for veterans
This project tests a new PET imaging approach to help diagnose and guide treatment for liver cancer in veterans.
-
Integrative Analysis of Lung Cancer Risk and Its Causes
A large, multi-part study at the University of New Mexico is exploring why lung cancer happens and how to better prevent and detect it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.